Reimagining drug development as it should be

With powerful, purpose-built data set to drive efficient creation of machine learning models, Creyon engineers oligonucleotide-based medicines (OBMs) for safe, precise gene-centric therapies with unprecedented speed and predictable efficacy and safety.